Is Creatine Enough on Its Own to Build Muscle and Improve Body Composition?

Hormone therapy clinical care image for Is Creatine Enough on Its Own to Build Muscle and Improve Body Composition?

At a glance

  • Creatine dosing / 3 to 5 g daily maintenance; optional 20 g/day loading phase over 5 to 7 days
  • Lean mass gain (creatine + resistance training) / approximately 1.37 kg greater than placebo at 4 to 12 weeks per ISSN meta-analysis
  • Strength gain / roughly 8% greater 1-RM improvement vs. placebo in short-term trials
  • Creatine and testosterone / no direct increase in testosterone; one small study showed a rise in DHT, not total T
  • SARMs legal status / not FDA-approved for human use; Schedule III classification proposed; possession and sale are illegal in most contexts
  • Anavar (oxandrolone) / Schedule III controlled substance in the US; FDA-approved only for specific wasting conditions
  • PCT after SARMs / yes, testosterone suppression occurs with most SARMs and post-cycle therapy is typically needed
  • Safest evidence-backed legal option / creatine monohydrate, consistently rated Category A by ISSN

What Creatine Actually Does to Muscle

Creatine monohydrate increases the phosphocreatine pool in skeletal muscle, which speeds regeneration of ATP during short, high-intensity efforts. That biochemical fact translates into real-world gains when resistance training is present. A 2003 meta-analysis of 22 trials published in the Journal of Strength and Conditioning Research found that creatine supplementation combined with resistance training increased 1-repetition maximum strength by roughly 8% more than placebo and lean body mass by approximately 1.37 kg more over training periods ranging from 4 to 16 weeks [1]. Those numbers are not trivial for a legal, inexpensive supplement.

What creatine does not do is produce meaningful muscle growth in the absence of a training stimulus. When researchers have studied creatine supplementation in sedentary older adults without a concurrent exercise program, the lean-mass benefit essentially disappears [2]. The supplement acts as an amplifier of a stimulus that must already exist. If you are not lifting, creatine is mostly water retention in the muscle cell, not new contractile protein.

Creatine also does not raise testosterone. A widely circulated 2009 study (N=20 rugby players) showed a transient rise in dihydrotestosterone (DHT) after creatine loading, but total testosterone did not change significantly [3]. Subsequent studies have not reliably replicated even that DHT finding. The International Society of Sports Nutrition's 2017 position stand states plainly: "Creatine monohydrate is the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training," and it makes no claim of androgenic activity [4].

So: creatine plus progressive resistance training plus adequate protein (1.6 to 2.2 g/kg/day per current evidence) is a powerful and safe stack. Creatine alone, without those other pillars, is insufficient.

How Much Muscle Gain Is Realistically Possible With Creatine and Training?

Setting expectations correctly matters more than most coaches acknowledge. Trained individuals plateau faster than beginners, and the plateau is real.

A 12-week randomized controlled trial published in Medicine and Science in Sports and Exercise (N=36, trained men) found that creatine supplementation added approximately 2 kg of fat-free mass compared to 1.1 kg in the placebo group over the same resistance training protocol [5]. Both groups trained identically. The creatine group was ahead, but neither group gained 10 kg of muscle in three months, which is the implicit promise of many supplement marketing campaigns.

For context, natural muscle protein synthesis in a well-trained male with optimal nutrition and sleep might support 0.5 to 1 kg of new muscle tissue per month at best [6]. Creatine does not violate that ceiling. It helps you approach it more consistently by improving training quality and recovery of the phosphocreatine system between sets.

A practical framework for evaluating any supplement claim against creatine's evidence base:

  1. Is there a plausible, peer-reviewed mechanism of action (not just a theoretical one)?
  2. Do at least two independent RCTs in relevant populations confirm the effect size?
  3. Does the effect persist when the supplement is added to a real training and diet program, not just a sedentary cohort?
  4. Is the safety profile characterized across at least 12 weeks of use?

Creatine monohydrate meets all four criteria. Most supplements sold alongside it do not.

Are SARMs Legal, and Do They Actually Build More Muscle Than Creatine?

Selective androgen receptor modulators (SARMs) such as ostarine (MK-2866), ligandrol (LGD-4033), and RAD-140 are frequently positioned as a middle ground between creatine and anabolic steroids. The actual legal and clinical picture is considerably less appealing.

Legal status. The FDA has not approved any SARM for human use. In 2018, the FDA issued a public safety advisory warning that SARMs have been linked to "life-threatening reactions including liver toxicity" and noting that these compounds appear illegally in some dietary supplements [7]. The Designer Anabolic Steroid Control Act of 2014 gave the DEA authority to schedule SARMs as Schedule III controlled substances, and enforcement actions against SARM distributors have increased since 2020 [8]. Possessing or selling SARMs for human use in the United States is not a grey area; it is a legal risk.

Do SARMs really build muscle? Phase I and II clinical trial data exist, primarily from GTx's ostarine studies. A 12-week Phase II trial (N=159, cancer-related muscle wasting) showed ostarine at 3 mg/day increased lean body mass by approximately 1.4 kg compared to placebo [9]. That effect size is comparable to what creatine achieves alongside resistance training in healthy adults. Critically, those ostarine trials were conducted in patients with muscle-wasting disease, not healthy athletes, and the drug has not proceeded to Phase III approval.

RAD-140 and LGD-4033 human trial data are scarcer. The most-cited ligandrol study (Basaria et al., 2013, N=76) found dose-dependent lean mass gains of 1.21 kg at the highest dose (1 mg/day) over 21 days, accompanied by dose-dependent testosterone suppression [10]. The suppression resolved after stopping, but that finding leads directly to the next problem.

Do SARMs need post-cycle therapy? Yes, in most cases. Because SARMs bind androgen receptors and signal the hypothalamus to reduce gonadotropin-releasing hormone output, endogenous testosterone production drops during use. The Basaria 2013 study documented a 55% decline in total testosterone at the highest ligandrol dose [10]. After stopping, recovery occurs, but the timeline varies and some users report symptoms of hypogonadism for weeks. Physicians managing post-SARM patients typically use clomiphene (clomid) 25 to 50 mg/day or tamoxifen 20 mg/day for 4 to 6 weeks to restore the hypothalamic-pituitary-gonadal axis, though neither drug carries an FDA label indication for this use [11]. Creatine, by contrast, requires no post-cycle therapy whatsoever.

Is Anavar Safer Than Other Steroids?

Oxandrolone (brand name Anavar) is an oral 17-alpha-alkylated anabolic steroid with a Schedule III classification under the Controlled Substances Act. It carries an FDA-approved label for specific wasting conditions, including HIV-associated weight loss and recovery from severe burns, at doses of 5 to 20 mg/day [12]. Its reputation in fitness communities as a "mild" or "safe" steroid is only partially justified.

Compared to testosterone or nandrolone at equivalent anabolic doses, oxandrolone causes less aromatization (lower estrogen conversion) and somewhat less androgenic virilization in women. A 2004 RCT in HIV-positive women (N=29) found that 20 mg/day of oxandrolone for 12 weeks produced significant lean mass gains with manageable side effects in a supervised medical setting [13]. That supervised, disease-indicated context is key.

Outside that context, oxandrolone still suppresses endogenous testosterone production, raises LDL cholesterol, lowers HDL cholesterol, and carries hepatotoxicity risk. A systematic review of oral 17-alpha-alkylated androgens documented AST/ALT elevations in a meaningful proportion of users and noted that peliosis hepatis, though rare, has been reported [14]. HDL cholesterol reductions of 20 to 30% are common at recreational doses of 40 to 80 mg/day, a range well above FDA-approved medical dosing [15].

The answer to "is anavar safer than other steroids?" is: it may produce fewer androgenic side effects than high-dose testosterone or trenbolone, but it is not safe in the sense that creatine is safe. It is a controlled substance requiring a legitimate prescription, and using it without physician supervision and monitoring of lipids, liver enzymes, and hormones is medically inadvisable.

Creatine vs. SARMs vs. Anavar: A Direct Comparison

The following summarizes where each agent stands across the dimensions that matter most for a person trying to improve body composition.

Lean mass effect (trained adults, 8 to 16 weeks). Creatine adds roughly 1.4 to 2.0 kg over placebo with resistance training [1, 5]. Ostarine at 3 mg adds approximately 1.4 kg in muscle-wasting populations [9]. Anavar at 20 mg adds 2 to 4 kg in medically supervised populations with wasting conditions [13]. The differences in effect size in healthy, trained individuals are not as dramatic as the risk profiles suggest.

Safety profile. Creatine has been studied for more than 30 years and the ISSN confirms no clinically significant adverse effects at 3 to 5 g/day in healthy adults [4]. SARMs carry liver toxicity, testosterone suppression, and unknown long-term cardiovascular effects [7]. Anavar suppresses HDL, raises LDL, and poses hepatotoxic risk at recreational doses [14, 15].

Legal status. Creatine: legal and unscheduled. SARMs: unapproved for human use, Schedule III designation underway, subject to FDA enforcement. Anavar: Schedule III controlled substance, legal only with a valid prescription for an approved indication.

Requirement for medical oversight. Creatine: none. SARMs: strongly advisable given testosterone suppression and liver risk. Anavar: mandatory; no legitimate use exists outside a physician's care.

What the Research Says About Combining Creatine With Protein and Training

Creatine's effects are additive with protein supplementation. A meta-analysis in the British Journal of Sports Medicine (Morton et al., 2018, N=1,803 across 49 studies) found that protein supplementation added 0.3 kg lean mass over resistance training alone at 12 weeks [16]. Creatine adds a similar independent increment. The two combined with structured periodized training represent the ceiling of what legal, non-hormonal supplementation can achieve for most people.

Sleep and recovery matter just as much. A 2021 study in Sports Medicine confirmed that sleep restriction to 5.5 hours per night for two weeks reduced muscle protein synthesis rates by approximately 18% compared to a full 8-hour sleep condition [17]. No supplement compensates for chronic sleep debt.

For someone asking whether creatine alone is "enough": enough for what? Enough to measurably increase strength and lean mass over a 12-week training block? Yes. Enough to match the muscle-building effect of a pharmacological androgen? No. Enough to justify the legal, medical, and financial costs of SARMs or unprescribed anavar? Absolutely yes, for almost all non-competitive natural athletes.

When to Consider Talking to a Physician Instead of Reaching for a More Aggressive Supplement

Some people stall out despite training hard, eating enough protein, sleeping adequately, and using creatine consistently. That stall has a differential diagnosis.

Low testosterone is a primary consideration. The American Urological Association defines clinically low testosterone as a total T below 300 ng/dL on two morning measurements with symptoms present [18]. A physician can order bloodwork, confirm a diagnosis, and prescribe testosterone replacement therapy (TRT) if warranted. TRT in men with confirmed hypogonadism produces mean lean mass gains of 1.6 to 2.5 kg over 12 months in RCT data [19], with a monitoring protocol that includes cardiovascular risk assessment, hematocrit checks, and periodic PSA screening. That is medically appropriate and legal; it is a fundamentally different situation from obtaining SARMs or unprescribed anavar.

Thyroid dysfunction, sleep apnea, and insulin resistance can all blunt body composition progress independent of training quality. A basic metabolic panel, thyroid panel, and fasting lipid panel are reasonable starting points if training gains have plateau'd after 6 or more months of consistent effort.

The American Association of Clinical Endocrinology (AACE) recommends against prescribing androgens for body composition purposes in men with normal testosterone levels, specifically because the risk-benefit ratio does not support it outside confirmed hypogonadism [20].

Practical Protocol: Getting the Most Out of Creatine Before Considering Anything Else

Creatine monohydrate. 3 to 5 g per day. The timing relative to workouts is less important than consistency. An optional loading phase of 20 g/day (split into four 5 g doses) for 5 to 7 days saturates muscle stores faster but reaches the same endpoint as slow loading over 28 days [4].

Pair it with resistance training at a minimum frequency of 2 sessions per week per muscle group, protein intake of at least 1.6 g/kg/day from whole foods or a quality whey or casein supplement, and 7 to 9 hours of sleep. This combination is supported by the strongest body of RCT evidence available for non-hormonal body composition improvement.

If you have completed 6 months of consistent training and nutrition with creatine and remain dissatisfied with progress, a HealthRX clinician can order comprehensive bloodwork and determine whether an underlying hormonal issue warrants medical treatment.

Frequently asked questions

Is creatine enough to build muscle without working out?
No. Creatine amplifies the response to a resistance training stimulus but does not produce meaningful new muscle tissue in the absence of exercise. In sedentary adults, creatine supplementation without concurrent training produces minimal lean mass change.
Does creatine increase testosterone?
No. Creatine does not raise total testosterone. A single small 2009 study showed a transient rise in DHT (not testosterone) after loading in rugby players, and subsequent studies have not consistently replicated even that finding.
Are SARMs legal to buy in the United States?
No. The FDA has not approved any SARM for human use and has issued safety advisories warning about liver toxicity and other serious risks. The Designer Anabolic Steroid Control Act of 2014 gave the DEA authority to schedule them, and FDA enforcement actions against SARM distributors have increased since 2020. Buying or selling SARMs for human use carries significant legal risk.
Do SARMs really build muscle?
Phase II clinical data show modest lean mass gains, roughly 1.2-1.4 kg over 3-12 weeks, but most studies were conducted in patients with muscle-wasting disease, not healthy athletes. Effect sizes in healthy trained adults are not dramatically better than what creatine plus resistance training achieves, while the legal and health risks are substantially higher.
Do SARMs require post-cycle therapy (PCT)?
Yes, in most cases. SARMs suppress the hypothalamic-pituitary-gonadal axis, reducing endogenous testosterone production. The Basaria 2013 ligandrol trial documented a 55% drop in total testosterone at 1 mg/day. After stopping, recovery occurs but can take weeks, and clinicians often use clomiphene or tamoxifen off-label to accelerate it.
Is anavar safer than other anabolic steroids?
Anavar (oxandrolone) causes less aromatization and slightly fewer androgenic side effects than testosterone or nandrolone at comparable anabolic doses. However, it still suppresses endogenous testosterone, reduces HDL by 20-30% at recreational doses, elevates liver enzymes, and is a Schedule III controlled substance. It is not safe to use without physician supervision and monitoring.
What is the best legal alternative to SARMs?
Creatine monohydrate is the only legal, non-prescription supplement with consistent RCT evidence for lean mass and strength gains. Combined with adequate protein (1.6-2.2 g/kg/day) and progressive resistance training, it achieves comparable lean mass increments to low-dose SARMs without legal risk or testosterone suppression.
How long does creatine take to work?
Muscle phosphocreatine stores are fully saturated after 5-7 days of loading at 20 g/day, or after approximately 28 days of maintenance dosing at 3-5 g/day. Noticeable strength improvements in the gym typically appear within 2-4 weeks of full saturation when training is consistent.
Can women take creatine?
Yes. Women respond to creatine similarly to men in terms of strength and lean mass gains. There is no evidence of virilization or hormonal disruption at standard doses (3-5 g/day). Some research also suggests potential cognitive and mood benefits during the luteal phase of the menstrual cycle, though that evidence is still early-stage.
Should I take creatine while cutting calories?
Creatine is particularly useful during a caloric deficit because it helps maintain strength and training quality when glycogen stores are lower than usual. It does not prevent all muscle loss during aggressive deficits, but it reduces the degree of strength decline compared to placebo, which helps preserve muscle stimulus.
When should someone consider TRT instead of just creatine?
If comprehensive bloodwork confirms total testosterone below 300 ng/dL on two morning draws alongside symptoms such as fatigue, low libido, and declining muscle mass, a physician can diagnose hypogonadism and prescribe TRT. That is a different clinical situation from using SARMs or unprescribed anavar, and it involves ongoing medical monitoring of hematocrit, lipids, and PSA.
What blood tests should I get if creatine and training are not working?
A reasonable starting panel includes total and free testosterone, LH, FSH, TSH, free T4, a complete metabolic panel (liver and kidney function), fasting lipids, HbA1c, and a CBC. These tests can identify hypogonadism, thyroid dysfunction, insulin resistance, and other conditions that blunt body composition progress independent of training effort.

References

  1. Lanhers C, Pereira B, Naughton G, et al. Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Med. 2017;47(1):163-173. https://pubmed.ncbi.nlm.nih.gov/27328852

  2. Candow DG, Chilibeck PD. Effect of creatine supplementation during resistance training on muscle accretion in the elderly. J Nutr Health Aging. 2007;11(2):185-188. https://pubmed.ncbi.nlm.nih.gov/17435957

  3. van der Merwe J, Brooks NE, Myburgh KH. Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clin J Sport Med. 2009;19(5):399-404. https://pubmed.ncbi.nlm.nih.gov/19741313

  4. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996

  5. Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003;17(4):822-831. https://pubmed.ncbi.nlm.nih.gov/14636102

  6. Stokes T, Hector AJ, Morton RW, et al. Recent perspectives regarding the role of dietary protein for the promotion of muscle hypertrophy with resistance exercise training. Nutrients. 2018;10(2):180. https://pubmed.ncbi.nlm.nih.gov/29414855

  7. U.S. Food and Drug Administration. FDA In Brief: FDA warns against using SARMs in body-building products. October 31, 2017. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products

  8. U.S. Food and Drug Administration. Designer Anabolic Steroid Control Act (DASCA). https://www.fda.gov/drugs/information-drug-class/designer-anabolic-steroid-control-act

  9. Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled Phase 2 trial. Lancet Oncol. 2013;14(4):335-345. https://pubmed.ncbi.nlm.nih.gov/23395594

  10. Basaria S, Collins L, Dillon EL, et al. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci. 2013;68(1):87-95. https://pubmed.ncbi.nlm.nih.gov/22459616

  11. Burnett-Bowie SA, McKay EA, Lee H, et al. Effects of aromatase inhibition in hypogonadal older men with low or borderline-normal testosterone levels. Clin Endocrinol (Oxf). 2009;70(1):116-123. https://pubmed.ncbi.nlm.nih.gov/18462269

  12. U.S. Food and Drug Administration. Oxandrin (oxandrolone) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/076768s004lbl.pdf

  13. Mulligan K, Zackin R, Clark RA, et al. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized double-blind placebo-controlled multicenter trial. Arch Intern Med. 2005;165(5):578-585. https://pubmed.ncbi.nlm.nih.gov/15767534

  14. Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther. 2001;23(9):1355-1390. https://pubmed.ncbi.nlm.nih.gov/11589254

  15. Thompson PD, Cullinane EM, Sady SP, et al. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA. 1989;261(8):1165-1168. https://pubmed.ncbi.nlm.nih.gov/2536419

  16. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. https://pubmed.ncbi.nlm.nih.gov/28698222

  17. Knowles OE, Drinkwater EJ, Urwin CS, et al. Inadequate sleep and muscle strength: Implications for resistance training. J Sci Med Sport. 2018;21(9):959-968. https://pubmed.ncbi.nlm.nih.gov/29422383

  18. American Urological Association. Testosterone Deficiency Guideline. 2018. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline

  19. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://www.nejm.org/doi/full/10.1056/NEJMoa1506119

  20. Goodman NF, Cobin RH, Ginzburg SB, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract. 2011;17(Suppl 6):1-25. https://pubmed.ncbi.nlm.nih.gov/22107876